Shiv Kushawaha

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Asperuloside as a promising multi-target agent for Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
  Inflammopharmacology 2025 DOI: 10.1007/s10787-025-01869-w
  +Save
• The silent threat: Pelvic inflammatory disease and long-term health outcomes with management
  Journal of Endometriosis and Pelvic Pain Disorders 2025 DOI: 10.1177/22840265251350207
  +Save
• Repurposing Saroglitazar for neurodegenerative disorders: insight into molecular signalling pathways and neuroprotective modulations
  Inflammopharmacology 2025 DOI: 10.1007/s10787-025-01805-y
  +Save
• Omentin 1: A Promising Regulator and Therapeutic Target in the Battle against Obesity, Diabetes, and Alzheimer’s Disease
  Current Drug Therapy 2025 DOI: 10.2174/0115748855296758240408040336
  +Save
• “Advances in biomarker discovery and diagnostics for alzheimer’s disease”
  Neurological Sciences 2025 DOI: 10.1007/s10072-025-08023-y
  +Save
• Auranofin-loaded PLGA Nanoparticles for Neuroprotection against Aluminium-induced Alzheimer’s Disease
  Current Pharmaceutical Design 2025 DOI: 10.2174/0113816128336703241202182209
  +Save
• Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters
  Naunyn-Schmiedeberg's Archives of Pharmacology 2024 DOI: 10.1007/s00210-024-03253-x
  +Save
• Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer’s disease
  Brain Research 2024 DOI: 10.1016/j.brainres.2024.148906
  +Save
• Neuroprotective Effect of Aurothioglucose-Loaded PLGA Nanoparticles in an Aluminum Chloride-Induced Rat Model of Alzheimer's Disease
  Research Journal of Pharmacy and Technology 2024 DOI: 10.52711/0974-360x.2024.00118
  +Save
• DEVELOPMENT AND EVALUATION OF HERBO SYNTHETICGEL: A NOVEL TREATMENT FOR PSORIASIS
  International Journal of Pharmaceutical Sciences and Research 2021 DOI: 10.13040/ijpsr.0975-8232.12(9).4745-52
  +Save